4 October 2017

MIBio 2017: Stability of Biopharmaceuticals - From Molecular Interactions to Successful Products

Organised by:

SCI's Colloid & Surface Chemistry Group, RSC Colloid & Interface Science Group and the Formulation Science and Technology Group (FSTG)

Downing College, Cambridge, UK

Registration Closed

This event is no longer available for registration.

Synopsis

The MIBio conference series engages world leading experts from industry and academia in a discussion on how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly and safer therapeutic products.

Whilst monoclonal antibodies still dominate the product pipelines, there is an increasing number of different product types in development including antibody fragments, protein conjugates, bispecific /tri-specific antibodies, cell and gene therapy products and more complex formats, as well as a large variety of peptides or nucleotides, each with specific stability and drug delivery challenges. MIBio 2017 will focus on discussing these challenges as well as the latest advances in understanding molecular interactions, formulation strategies and device options to overcome them.

MIBio 2017 expects more than 100 industrial and academic research attendees to create an interesting and stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation of formulation technologies. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day. We look forward to seeing you at MIBio 2017!

Attendees

MIBio 2017 as in previous years expects more than 100 industrial and academic research attendees to create an interesting and stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation of formulation technologies.

Programme

Day 1 - 4 October 2017

08:00
Registration
09:00
Opening remarks
Morning Session
09:15
The key roles of formulation and orthogonal analytical methods in the success of biopharmaceuticals Prof Tudor Arvinte, University of Geneva and Therapeomic Inc, Switzerland
09:45
Formulation development challenges of bi-specific antibodies Stephanie Davies, MedImmune, UK
10:15
Speed Networking
11:15
Stability challenges with ADCs and mAbs with extended Fab regions Adithya Balasubramanian, Lonza Drug Product Services, Switzerland
11:45
Development of parenteral multidose products – the challenge of preservatives Helen Sjogren, Principal Scientist, Ferring, Denmark
1215
Lunch, exhibition and poster viewing
Afternoon Session
13:30
Introduction
13:45
Discussion Panel
14:45
Exhibitors Highlights
1530
Refreshments, exhibition and poster viewing
16:00
Formulation and process development considerations for oligonucleotides intended for intrathecal injection Rob Simler, Biogen, USA
16:30
Glycocconjugate vaccines against bacterial infections based on synthetic glycans Prof Peter Seeberger, Max Planck Institute of Colloids and Interfaces, Germany
17:00
Concluding remarks
17:10
Conference close
Venue and Contact

Downing College

The Howard Theatre
Downing College
Regent Street
Cambridge
CB2 1DQ

Conference Team

+44 (0)20 7598 1561

Email: deborah@constableandsmith.com

Booking Process/Deadlines
Online registration is now open! Cilck here to go to the booking website.

Additional Info

Call for posters

Abstracts for poster presentations at MIBio 2016 are now being invited.
Please submit a 200 - 250 words abstract as a Word document to jan.jezek@formulation.org.uk no later than Friday 15 September 2017.
Please note that you will need to register to be able to present your poster at MIBio 2017.

Organising Committee

  • Nicholas Darton, SCI/Arecor
  • Jan Jezek, Arecor
  • Tejash Shah, GlaxoSmithKline
  • Stephen Harding, University of Nottingham
  • Bernardo Perez-Ramirez, Sanofi

Exhibition

The conference venue at Downing College offers an excellent exhibiting space. We aim to build on the very positive feedback received from delegates, speakers, exhibitors and sponsors after the previous MIBio meetings to make MIBio 2017 an even more engaging and memorable event. The event will be attended by scientists and decision makers from Biotech and Pharma companies as well as academics with interest in macromolecular interactions and biopharmaceutical formulation. This will provide a unique opportunity for Sponsors and Exhibitors to gain a considerable exposure to their target audience.

For more information on available packages, please email jan.jezek@formulation.org.uk